Glenmede Trust CO Na Bluebird Bio, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $26,400 - $96,600	20,000 New	20,000 $27,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $8,800 - $12,134	-320 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $3,719 - $4,725	108 Added 50.94%	320 $17,000
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $4,339 - $7,355	160 Added 307.69%	212 $12,000
Q1 2019 May 14, 2019	SELL	$64.44 - $104.11 $386 - $624	-6 Reduced 10.34%	52 $8,000
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $3,427 - $5,409	58 New	58 $5,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.